Toxic ligand conjugates as tools in the study of receptor-ligand interactions
✍ Scribed by Harvey R. Herschman; David L. Simpson; Daniel B. Cawley
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 856 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We have constructed hybrid proteins in which the toxic A chains of ricin or diptheria toxin have been linked to either asialofetuin, fetuin, or epidermal growth factor (EGF). Both ASF‐RTA and ASF‐DTA are potent toxins on cultured rat hepatocytes, cells that display the asialoglycoprotein receptor. Toxicity of these two compounds is restricted to hepatocytes and can be blocked by asialoglycoproteins but not the native glycoproteins or asialoagalactoglycoprotein derivatives, indicating that the toxicity of the conjugates is mediated by the hepatic asialoglycoprotein receptor. The EGF‐RTA conjugate is an extremely potent toxin on cells that can bind the hormone, but is only poorly effective on cells that are unable to bind EGF. The EGF‐DTA conjugate, in contrast, is unable to kill 3T3 cells and is at least two orders of magnitude less effective than EGF‐RTA on A431 cells, a cell line with 1‐2 × 10^6^ EGF receptors per cell. However, when EGF‐RTA and EGF‐DTA were tested on primary liver hepatocyte cultures, which were susceptible to both ASF‐RTA and ASF‐DTA, both EGF conjugates were potent toxins. Sensitivity of the hepatocyte cultures to ricin toxicity increases slightly during a 52‐hr culture period. In contrast, sensitivity to EGF‐RTA and ASF‐RTA decline dramatically during this period. Receptors for both ligands remain plentiful on the cell surface during this time.
📜 SIMILAR VOLUMES
Fluorine is often used in drug-design efforts to enhance the pharmacokinetic properties of biologically active compounds. Additionally fluorine nuclei ( 19 F) have properties that are well suited to current pharmaceutical NMR screening programs. Together, these considerations have motivated our inte
Approximately equal amounts of Iz51-mAb 225 (a monoclonal antibody recognizing the human e idermal growth factor receptor) and 1251-labeled epidermal growth factor (P251-EGF) were bound by HeLa cells. However, these two EGF receptor bindin moieties had different fates after binding. Sixty percent of
Chemiluminescent molecules can be readily detected in the range 10(-15) to 10(-18) mol, and potentially at least down to 10(-20) mol reacting/s. The chemiluminescent compound aminobutylethylisoluminol (ABEI) and its isothiocyanate derivative have been synthesized. The ABEI was coupled to rabbit immu